Safety endpoints
| Catfish group (n=113) | Solitaire group (n=114) | |
| Serious adverse events | ||
| Study device-associated | 15 (13.3) | 12 (10.5) |
| Procedure-associated | ||
| Local puncture site haematoma | 0 | 1 (0.9) |
| Embolisation in a new vascular territory | 1 (0.9) | 3 (2.6) |
| Arterial perforation | 2 (1.8) | 1 (0.9) |
| Vasospasm | 17 (15.0) | 9 (7.9) |
| Subarachnoid haemorrhage | 5 (4.4) | 4 (3.5) |
| Symptomatic haemorrhage | 9 (8.0) | 9 (7.9) |
| All-cause death by 90 days | 20 (17.7) | 18 (15.8) |
Data are n (%).